• OPEN AN ACCOUNT
Indian Indices
Nifty
24,631.30 11.95
(0.05%)
Sensex
80,597.66 57.75
( 0.07%)
Bank Nifty
55,341.85 160.40
( 0.29%)
Nifty IT
34,833.20 140.25
( 0.40%)
Global Indices
Nasdaq
44,972.99 40.72
(0.09%)
Dow Jones
6,471.77 -17.77
(-0.27%)
Hang Seng
43,330.92 681.66
(1.60%)
Nikkei 225
9,138.90 -38.34
(-0.42%)
Forex
USD-INR
87.57 0.06
(0.07%)
EUR-INR
102.22 -0.17
(-0.17%)
GBP-INR
118.73 0.16
(0.13%)
JPY-INR
0.60 0.00
(0.37%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
52.32
1041.35
EPS(TTM)
Face Value()
Div & Yield %
16.89
10
0
 

Polson standalone net profit rises 154.55% in the March 2025 quarter
May 31,2025
Net profit of Polson rose 154.55% to Rs 1.40 crore in the quarter ended March 2025 as against Rs 0.55 crore during the previous quarter ended March 2024. Sales rose 2.73% to Rs 24.84 crore in the quarter ended March 2025 as against Rs 24.18 crore during the previous quarter ended March 2024.

For the full year,net profit rose 0.58% to Rs 5.23 crore in the year ended March 2025 as against Rs 5.20 crore during the previous year ended March 2024. Sales declined 3.23% to Rs 93.28 crore in the year ended March 2025 as against Rs 96.39 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales24.8424.18 3 93.2896.39 -3
OPM %14.7712.82 -16.1016.40 -
PBDT3.652.45 49 13.2013.07 1
PBT1.911.08 77 7.147.32 -2
NP1.400.55 155 5.235.20 1